Brind.

William Blair upgraded shares of Beam Therapeutics to strong-buy, while Bank of America reaffirmed its buy rating. Amy Simon also sold shares.

1 report, 1 independent Updated Oct 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

William Blair upgraded shares of Beam Therapeutics to strong-buy, while Bank of America reaffirmed its buy rating. Amy Simon also sold shares.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped